Inhibitors of Caspases 3 and 7
J ournal of Medicinal Chemistry, 2001, Vol. 44, No. 12 2025
(6) Garcia-Calvo, M.; Peterson, E. P.; Leiting, B.; Ruel, R.; Nicholson,
D. W.; Thornberry, N. A. Inhibition of human caspases by
peptide-based and macromolecular inhibitors. J . Biol. Chem.
1998, 273, 32608-32613.
(7) Schotte, P.; Declercq, W.; Van Huffel, S.; Vandenabeele, P.;
Beyaert, R. Non-specific effects of methyl ketone peptide inhibi-
tors of caspases. FEBS Lett. 1999, 442, 117-121.
(8) Porter, A. G.; J a¨nicke, R. U. Emerging roles of caspase-3 in
apoptosis. Cell Death Differ. 1999, 6, 99-104.
(9) Hansch, C.; Leo, A.; Hoekman, D. In Exploring QSAR: Hydro-
phobic, Electronic, and Steric Constants; Heller, S. R., Ed.;
American Chemical Society: Washington, DC, 1995.
(10) Iyer, R. A.; Hanna, P. E. N-(Carbobenzyloxy)isatin: A slow
binding R-keto lactam inhibitor of R-chymotrypsin. Bioorg. Med.
Chem. Lett. 1995, 5, 89-92.
(25) Chinnaiyan, A. M.; Orth, K.; O’Rourke, K.; Duan, H.; Poirier,
G. G.; Dixit, V. M. Molecular ordering of the cell-death pathway-
bcl-2 and bcl-xL function upstream of the ced-3-like apoptotic
proteases. J . Biol. Chem. 1996, 271, 4573-4576.
(26) Srinivasula, S. M.; Ahmad, M.; Fernandes-Alnemri, T.; Litwack,
G.; Alnemri, E. S. Molecular ordering of the fas-apoptotic
pathway: The fas/APO-1 protease mch5 is a crmA-inhibitable
protease that activates multiple ced-3/ICE-like cysteine pro-
teases. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 14486-14491.
(27) Takahashi, A.; Hirata, H.; Yonehara, S.; Imai, Y.; Lee, K.-K.;
Moyer, R. W.; Turner, P. C.; Mesner, P. W.; Okazaki, T.; Sawai,
H.; Kishi, S.; Yamamoto, K.; Okuma, M.; Sasada, M. Affinity
labeling displays the stepwise activation of ICE-related proteases
by fas, staurosporine, and crmA-sensitive caspase-8. Oncogene
1997, 14, 2741-2752.
(11) Webber, S. E.; Tikhe, J .; Worland, S. T.; Fuhrman, S. A.;
Hendrickson, T. F.; Matthews, D. A.; Love, R. A.; Patick, A. K.;
Meador, J . W.; Ferre, R. A.; Brown, E. L.; DeLisle, D. M.; Ford,
C. E.; Binford, S. L. Design, synthesis, and evaluation of
nonpeptidic inhibitors of human rhinovirus 3C protease. J . Med.
Chem. 1996, 39, 5072-5082.
(12) Mittl, P. R. E.; Di Marco, S.; Krebs, J . F.; Bai, X.; Karanewsky,
D. S.; Priestle, J . P.; Tomaselli, K. J .; Gru¨tter, M. G. Structure
of recombinant human CPP32 in complex with the tetrapeptide
acetyl-asp-val-ala-asp fluoromethyl ketone. J . Biol. Chem. 1997,
272, 6539-6547.
(13) Rotonda, J .; Nicholson, D. W.; Fazil, K. M.; Gallant, M.; Gareau,
Y.; Labelle, M.; Peterson, E. P.; Rasper, D. M.; Ruel, R.;
Vaillancourt, J . P.; Thornberry, N. A.; Becker, J . W. The
3-dimensional structure of apopain/CPP32, a key mediator of
apoptosis. Nat. Struct. Biol. 1996, 3, 619-625.
(14) Parkinson, A. Biotransformation of Xenobiotics. In Casarett and
Doull’s Toxicology; Klaassen, C. D., Ed.; McGraw-Hill: New
York, 1996; pp 120-121.
(15) Somasekhara, S.; Dighe, V. S.; Suthar, G. K.; Mukherjee, S. L.
Chlorosulphonation of isatins. Curr. Sci. 1965, 508
(16) A subsequent search of the literature shed some doubt on the
identity of the product described by Somasekhara et al. See:
Tomchin, A. B.; Rusakov, E. A. Semicarbazones and Thiosemi-
carbazones of the Heterocyclic Series XXXIII. Synthesis of
5-Sulfamidoisatin â-Thiosemicarbazone. Khim.-Farm. Zh. 1974,
23-25. The original characterization assumed the form of a
hydrochloride salt and relied on only N and Cl analysis. The
gem-dichloro derivative 11 prepared by the same means also
fits the combustion analysis data reported by Somasekhara and
thus strongly suggests that the initially proposed structure is
incorrect.
(28) Kouri, J . B.; Rosales-Encina, J . L.; Chaudhuri, P. P.; Luna, J .;
Mena, R. Apoptosis in human osteoarthritic cartilage: A mi-
croscopy report. Med. Sci. Res. 1997, 25, 245-248.
(29) Blanco, F. J .; Guitian, R.; Va´zquez-Martul, E.; Detoro, F. J .;
Galdo, F. Osteoarthritis chondrocytes die by apoptosis-A possible
pathway for osteoarthritis pathology. Arthritis Rheum. 1998, 41,
284-289.
(30) Hashimoto, S.; Ochs, R. L.; Komiya, S.; Lotz, M. Linkage of
chondrocyte apoptosis and cartilage degradation in human
osteoarthritis. Arthritis Rheum. 1998, 41, 1632-1638.
(31) Goldring, M. B.; Birkhead, J . R.; Suen, L.-F.; Yamin, R.; Mizuno,
S.; Glowacki, J .; Arbiser, J . L.; Apperley, J . F. Interleukin-1â-
modulated gene expression in immortalized human chondro-
cytes. J . Clin. Invest. 1994, 94, 2307-2316.
(32) Woo, M.; Hakem, R.; Soengas, M. S.; Duncan, G. S.; Shahinian,
A.; Ka¨gi, D.; Hakem, A.; Mccurrach, M.; Khoo, W.; Kaufman, S.
A.; Senaldi, G.; Howard, T.; Lowe, S. W.; Mak, T. W. Essential
contribution of caspase 3/CPP32 to apoptosis and its associated
nuclear changes. Genes Dev. 1998, 12, 806-819.
(33) Black, R. A.; Kronheim, S. R.; Merriam, J . E.; March, C. J .; Hopp,
T. P. A pre-aspartate-specific protease from human leukocytes
that cleaves pro-interleukin-1â. J . Biol. Chem. 1989, 264, 5323-
5326.
(34) Sleath, P. R.; Hendrickson, R. C.; Kronheim, S. R.; March, C.
J .; Black, R. A. Substrate specificity of the protease that
processes human interleukin-1â. J . Biol. Chem. 1990, 265,
14526-14528.
(35) Howard, A. D.; Kostura, M. J .; Thornberry, N.; Ding, G. J . F.;
Limjuco, G.; Weidner, J .; Salley, J . P.; Hogquist, K. A.; Chaplin,
D. D.; Mumford, R. A.; Schmidt, J . A.; Tocci, M. J . IL-1-
converting enzyme requires aspartic acid residues for processing
of the IL-1â precursor at two distinct sites and does not cleave
31-kDa IL-1R. J . Immunol. 1991, 147, 2964-2969.
(36) Marcelli, M.; Cunningham, G. R.; Haidacher, S. J .; Padayatty,
S. J .; Sturgis, L.; Kagan, C.; Denner, L. Caspase-7 is activated
during lovastatin-induced apoptosis of the prostate cancer cell
line LNCaP. Cancer Res. 1998, 58, 76-83.
(17) Martinez, F.; Naarmann, H. New isatin derivatives: Synthesis
and reactions. Synth. Met. 1990, 39, 195-203.
(18) Von Tacconi, G.; Righetti, P. P.; Desimoni, G. Einfache Darstel-
lung von N-substituierten Isatinen. J . Prakt. Chem. 1973, 315,
339-344.
(19) Yue, T. L.; Wang, C.; Romanic, A. M.; Kikly, K.; Keller, P.;
DeWolf, W. E., J r.; Hart, T. K.; Thomas, H. C.; Storer, B.; Gu,
J .-L.; Wang, X.; Feuerstein, G. Z. Staurosporine-induced
apoptosis in cardiomyocytes: A potential role of caspase-3. J .
Mol. Cell. Cardiol. 1998, 30, 495-507.
(20) Lee, D.; Long, S. A.; Adams, J . L.; Chan, G.; Vaidya, K. S.;
Francis, T. A.; Kikly, K.; Winkler, J . D.; Sung, C. M.; Debouck,
C.; Richardson, S.; Levy, M. A.; Dewolf, W. E.; Keller, P. M.;
Tomaszek, T.; Head, M. S.; Ryan, M. D.; Haltiwanger, R. C.;
Liang, P. H.; J anson, C. A.; McDevitt, P. J .; J ohanson, K.;
Concha, N. O.; Chan, W.; Abdel-Meguid, S. S. Potent and
selective nonpeptide inhibitors of caspases 3 and 7 inhibit
apoptosis and maintain cell functionality. J . Biol. Chem. 2000,
275, 16007-16014.
(37) Rokhlin, O. W.; Glover, R. A.; Cohen, M. B. Fas-mediated
apoptosis in human prostatic carcinoma cell lines occurs via
activation of caspase-8 and caspase-7. Cancer Res. 1998, 58,
5870-5875.
(38) Chandler, J . M.; Cohen, G. M.; Macfarlane, M. Different sub-
cellular distribution of caspase-3 and caspase-7 following Fas-
induced apoptosis in mouse liver. J . Biol. Chem. 1998, 273,
10815-10818.
(39) Agarwal, S.; Pande, A.; Saxena, V. K.; Choudhury, S. R.
Synthesis and pharmacological screening of 1-(substituted acyl/
aryloxy/arylsulphonyl)-2-oxo-3-(phenylsulphonylhydrazono)-5-
substituted indoles. Indian Drugs 1985, 22, 633-639.
(40) Borsche, W.; Weussmann, H.; Fritzsche, A. Untersuchungen u¨ber
Isatin und verwandte Verbindungen, V: U¨ ber Nitro-isatine.
Chem. Ber. 1924, 57, 1149-1152.
(41) Anders, E.; Opitz, A.; Bauer, W. Remote controlled nucleophi-
licity, 2: Lithiated CR-substituted 4-methylpyridines. Synthesis
1991, 1221-1230.
(21) Votta, B. J .; Levy, M. A.; Badger, A.; Bradbeer, J .; Dodds, R. A.;
J ames, I. E.; Thompson, S.; Bossard, M. J .; Carr, T.; Connor, J .
R.; Tomaszek, T. A.; Szewczuk, L.; Drake, F. H.; Veber, D. F.;
Gowen, M. Peptide aldehyde inhibitors of cathepsin K inhibit
bone resorption both in vitro and in vivo (see comments). J . Bone
Miner. Res. 1997, 12, 1396-1406.
(42) Garcia-Calvo, M.; Peterson, E. P.; Rasper, D. M.; Vaillancourt,
J . P.; Zamboni, R.; Nicholson, D. W.; Thornberry, N. A. Purifica-
tion and catalytic properties of human caspase family members.
Cell Death Differ. 1999, 6, 362-369.
(22) Wang, K. K. Calpain and caspase: can you tell the difference?
Trends Neurosci. 2000, 23, 20-26, 59 (erratum).
(23) Thornberry, N. A.; Rano, T. A.; Peterson, E. P.; Rasper, D. M.;
Timkey, T.; Garcia-Calvo, M.; Houtzager, V. M.; Nordstrom, P.
A.; Roy, S.; Vaillancourt, J . P.; Chapman, K. T.; Nicholson, D.
W. A combinatorial approach defines specificities of members
of the caspase family and granzyme B-functional relationships
established for key mediators of apoptosis. J . Biol. Chem. 1997,
272, 17907-17911.
(24) Fernandes-Alnemri, T.; Armstrong, R. C.; Krebs, J .; Srinivasula,
S. M.; Wang, L.; Bullrich, F.; Fritz, L. C.; Trapani, J . A.;
Tomaselli, K. J .; Litwack, G.; Alnemri, E. S. In vitro activation
of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine
protease containing two FADD-like domains. Proc. Natl. Acad.
Sci. U.S.A. 1996, 93, 7464-7469.
(43) Morrison, J . F.; Stone, S. R. Approaches to the study and analysis
of the inhibition of enzymes by slow- and tight-binding inhibitors.
Comments Mol. Cell. Biophys. 1985, 2, 347-368.
(44) Chapman, R. S.; Chresta, C. M.; Herberg, A. A.; Beere, H. M.;
Heer, S.; Whetton, A. D.; Hickman, J . A.; Dive, C. Further
characterisation of the in situ terminal deoxynucleotidyl trans-
ferase (Tdt) assay for the flow cytometric analysis of apoptosis
in drug resistant and drug sensitive leukaemic cells. Cytometry
1995, 20, 245-256.
(45) Gorczyca, W.; Gong, J .; Darzynkiewicz, Z. Detection of DNA
strand breaks in individual apoptotic cells by the in situ terminal
deoxynucleotidyl transferase and nick translation assays. Cancer
Res. 1993, 53, 1945-1951.